blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0970095

EP0970095 - NOVEL BENZIMIDAZOLE INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.09.2004
Database last updated on 10.12.2024
Most recent event   Tooltip03.09.2004No opposition filed within time limitpublished on 20.10.2004  [2004/43]
Applicant(s)For all designated states
Metabasis Therapeutics, Inc.
9390 Towne Centre Drive
San Diego, CA 92121 / US
[2003/44]
Former [2000/02]For all designated states
Metabasis Therapeutics Inc.
9390 Towne Centre Drive
San Diego, CA 92121 / US
Inventor(s)01 / KASIBHATLA, Srinivas, Rao
10788 Glendover Lane
San Diego, CA 92126 / US
02 / REDDY, K., Raja
4146 Federman Lane
San Diego, CA 92130 / US
03 / ERION, Mark, D.
13455 Mango Drive
Del Mar, CA 92104 / US
04 / DANG, Qun
7825 Roan Road
San Diego, CA 92129 / US
05 / SCARLATO, Gerard, R.
1121 Virginia Way
La Jolla, CA 92037 / US
06 / REDDY, M., Rami
9515 Easter Way 3
San Diego, CA 92121 / US
[2000/02]
Representative(s)Viering, Jentschura & Partner mbB Patent- und Rechtsanwälte
Grillparzerstraße 14
81675 München / DE
[N/P]
Former [2000/02]Viering, Jentschura & Partner
Postfach 22 14 43
80504 München / DE
Application number, filing date98909031.106.03.1998
[2000/02]
WO1998US04498
Priority number, dateUS19970040627P07.03.1997         Original published format: US 40627 P
[2000/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9839343
Date:11.09.1998
Language:EN
[1998/36]
Type: A1 Application with search report 
No.:EP0970095
Date:12.01.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 11.09.1998 takes the place of the publication of the European patent application.
[2000/02]
Type: B1 Patent specification 
No.:EP0970095
Date:29.10.2003
Language:EN
[2003/44]
Search report(s)International search report - published on:EP11.09.1998
ClassificationIPC:C07F9/6506, A61K31/675, C07F9/6558
[2000/02]
CPC:
C07F9/65068 (EP,US); A61P3/10 (EP); A61P9/10 (EP);
C07F9/65586 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/02]
TitleGerman:NEUE BENZIMIDAZOL INHIBITOREN DER FRUCTOSE-1,6-BISPHOSPHATASE[2000/02]
English:NOVEL BENZIMIDAZOLE INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE[2000/02]
French:NOUVEAUX INHIBITEURS DE BENZIMIDAZOLE DE FRUCTOSE-1,6-BISPHOSPHATASE[2000/02]
Entry into regional phase06.10.1999National basic fee paid 
06.10.1999Designation fee(s) paid 
06.10.1999Examination fee paid 
Examination procedure02.10.1998Request for preliminary examination filed
International Preliminary Examining Authority: EP
06.10.1999Examination requested  [2000/02]
07.05.2001Despatch of a communication from the examining division (Time limit: M06)
16.11.2001Reply to a communication from the examining division
10.12.2001Despatch of a communication from the examining division (Time limit: M06)
14.06.2002Reply to a communication from the examining division
17.01.2003Date of oral proceedings
03.03.2003Minutes of oral proceedings despatched
21.03.2003Communication of intention to grant the patent
31.07.2003Fee for grant paid
31.07.2003Fee for publishing/printing paid
Divisional application(s)EP03024556.7  / EP1402895
Opposition(s)30.07.2004No opposition filed within time limit [2004/43]
Fees paidRenewal fee
30.03.2000Renewal fee patent year 03
29.03.2001Renewal fee patent year 04
28.03.2002Renewal fee patent year 05
30.06.2003Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.03.200306   M06   Fee paid on   30.06.2003
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DA]EP0012909  (BAYER AG [DE]) [DA] 1-42* claim 1 *;
 [Y]EP0354322  (AMERICAN CYANAMID CO [US]) [Y] 1-52 * the whole document *;
 [Y]US5021443  (BRU-MAGNIEZ NICOLE [FR], et al) [Y] 1-52 * see column 9 and claims *;
 [Y]WO9407867  (PFIZER [US], et al) [Y] 1-52 * the whole document *;
 [Y]EP0604657  (OTSUKA PHARMA CO LTD [JP]) [Y] 1-52 * see page 4, lines 8-14; page 11, table 1; page 16, examples 24-26 *;
 [Y]WO9420508  (EISAI CO LTD [JP], et al) [Y] 1-52 * see page 242, examples 305 and 306; claims *;
 [DY]EP0620227  (HOECHST JAPAN [JP]) [DY] 1-52 * the whole document *;
 [DY]EP0427799  (GENSIA PHARMA [US]) [DY] 1-52 * the whole document *;
 [DY]  - KOHICHIRO YOSHINO, "Organic phosphorus compounds.2. Synthesis and coronary vasodilatator activity of (Benzothiazolylbenzyl)phosphonate derivatives.", JOURNAL OF MEDICINAL CHEMISTRY., WASHINGTON US, vol. 32, no. 7, pages 1528 - 1532, XP002066780 [DY] 1-52 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm00127a021
Examination   - Beilstein Registry Number 3221
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.